https://lungcancergroup.de/project/ 2018-07-18T11:21:04+00:00 https://lungcancergroup.de/en/project/evolutionary-cancer-modeling-using-growth-kinetics-of-drug-sensitiveresistant-cells-optimizes-dosing-strategies-for-egfr-mutant-nsclc/ 2015-07-01T10:00:04+00:00 https://lungcancergroup.de/en/project/developments-in-oncological-positron-emission-tomographycomputed-tomography-assessment/ 2015-12-07T14:48:09+00:00 https://lungcancergroup.de/project/targeted-therapy-for-patients-with-braf-mutant-lung-cancer-results-from-the-european-euraf-cohort/ 2015-12-18T15:43:50+00:00 https://lungcancergroup.de/project/impact-of-petct-image-reconstruction-methods-and-liver-uptake-normalization-strategies-on-quantitative-image-analysis/ 2015-12-18T15:44:06+00:00 https://lungcancergroup.de/project/phase-ii-study-of-nivolumab/ 2015-12-26T14:16:54+00:00 https://lungcancergroup.de/project/pik3ca-mutations-in-non-small-cell-lung-cancer-nsclc-genetic-heterogeneity-prognostic-impact-and-incidence-of-prior-malignancies/ 2015-12-26T14:24:19+00:00 https://lungcancergroup.de/project/met-ein-vielversprechendes-target/ 2015-12-26T15:02:14+00:00 https://lungcancergroup.de/wp-content/uploads/2015/12/MET_Ampl_1920x543.jpg https://lungcancergroup.de/project/alk-and-ros1-non-small-cell-lung-cancer-two-molecular-subgroups-sensitive-to-targeted-therapy/ 2015-12-26T15:11:51+00:00 https://lungcancergroup.de/project/frequent-mutations-in-chromatin-remodelling-genes-in-pulmonary-carcinoids/ 2015-12-26T15:39:38+00:00 https://lungcancergroup.de/project/ceritinib-in-alk-rearranged-non-small-cell-lung-cancer/ 2015-12-26T15:49:33+00:00 https://lungcancergroup.de/project/cd74-nrg1-fusions-in-lung-adenocarcinoma/ 2015-12-26T16:04:23+00:00 https://lungcancergroup.de/project/modeling-tumor-dynamics-and-overall-survival-in-advanced-non-small-cell-lung-cancer-treated-with-erlotinib-2/ 2015-12-26T16:17:02+00:00 https://lungcancergroup.de/project/rationale-for-co-targeting-igf-1r-and-alk-in-alk-fusion-positive-lung-cancer/ 2015-12-26T16:39:40+00:00 https://lungcancergroup.de/project/cell-autonomous-and-non-cell-autonomous-mechanisms-of-transformation-by-amplified-fgfr1-in-lung-cancer/ 2015-12-26T16:43:46+00:00 https://lungcancergroup.de/project/genomics-based-classification-human-lung-tumors/ 2015-12-28T13:43:58+00:00 https://lungcancergroup.de/project/fibroblast-growth-factor-receptor-1-fgfr1-amplification-potential-therapeutic-target-small-cell-lung-cancer/ 2015-12-28T13:45:44+00:00 https://lungcancergroup.de/project/complete-metabolic-response-patient-repeatedly-relapsed-non-small-cell-lung-cancer-harboring-ros1-gene-rearrangement-treatment-crizotinib/ 2015-12-28T13:47:10+00:00 https://lungcancergroup.de/project/activated-ret-ros-two-new-driver-mutations-lung-adenocarcinoma/ 2015-12-28T13:49:47+00:00 https://lungcancergroup.de/project/fgfr1-amplifications-squamous-cell-carcinomas-lung-diagnostic-therapeutic-implications/ 2015-12-28T13:51:06+00:00 https://lungcancergroup.de/project/tumor-vegfrvegfr2-autocrine-feed-forward-loop-triggers-angiogenesis-lung-cancer/ 2015-12-28T13:52:31+00:00 https://lungcancergroup.de/project/lung-cancer-molecular-pathology-personalized-therapy/ 2015-12-28T13:53:43+00:00 https://lungcancergroup.de/project/molecular-pathology-lungs-new-perspectives-next-generation-sequencing/ 2015-12-28T13:55:10+00:00 https://lungcancergroup.de/project/prognostic-impact-18ffluorothymidine-18ffluoro-d-glucose-baseline-uptakes-patients-lung-cancer-treated-first-line-erlotinib/ 2015-12-28T13:56:30+00:00 https://lungcancergroup.de/project/lessons-learned-lung-cancer-genomics-emerging-concept-individualized-diagnostics-treatment/ 2015-12-28T14:01:57+00:00 https://lungcancergroup.de/project/868/ 2015-12-30T10:52:59+00:00 https://lungcancergroup.de/project/870/ 2015-12-30T11:00:16+00:00 https://lungcancergroup.de/project/869/ 2015-12-30T11:00:30+00:00 https://lungcancergroup.de/project/871/ 2015-12-30T11:03:40+00:00 https://lungcancergroup.de/project/874/ 2015-12-30T11:05:01+00:00 https://lungcancergroup.de/project/873/ 2015-12-30T11:06:44+00:00 https://lungcancergroup.de/project/875/ 2015-12-30T11:08:10+00:00 https://lungcancergroup.de/project/877/ 2015-12-30T11:11:21+00:00 https://lungcancergroup.de/project/878/ 2015-12-30T11:26:41+00:00 https://lungcancergroup.de/project/879/ 2015-12-30T11:28:14+00:00 https://lungcancergroup.de/project/880/ 2015-12-30T12:13:49+00:00 https://lungcancergroup.de/project/881/ 2015-12-30T12:15:29+00:00 https://lungcancergroup.de/project/882/ 2015-12-30T12:16:52+00:00 https://lungcancergroup.de/project/883/ 2015-12-30T12:18:22+00:00 https://lungcancergroup.de/project/884/ 2015-12-30T12:19:50+00:00 https://lungcancergroup.de/project/872/ 2015-12-30T12:23:27+00:00 https://lungcancergroup.de/project/876/ 2015-12-30T12:26:03+00:00 https://lungcancergroup.de/project/everolimus-in-combination-with-pemetrexed-in-patients-with-advanced-non-small-cell-lung-cancer-previously-treated-with-chemotherapy-a-phase-i-study-using-a-novel-adaptive-bayesian-dose-escalation-mo/ 2015-12-30T13:45:24+00:00 https://lungcancergroup.de/project/alk-mutations-conferring-differential-resistance-to-structurally-diverse-alk-inhibitors/ 2015-12-30T13:46:53+00:00 https://lungcancergroup.de/project/a-crucial-requirement-for-hedgehog-signaling-in-small-cell-lung-cancer/ 2015-12-30T13:49:31+00:00 https://lungcancergroup.de/project/personalized-therapy-of-lung-cancer-cokinetics-of-tyrosine-kinase-inhibitors-focus-on-pyrimidines-pyridines-and-pyrroles/ 2015-12-30T13:50:59+00:00 https://lungcancergroup.de/project/insights-into-alk-driven-cancers-revealed-through-development-of-novel-alk-tyrosine-kinase-inhibitors/ 2015-12-30T13:54:30+00:00 https://lungcancergroup.de/project/mutations-in-the-ddr2-kinase-gene-identify-a-novel-therapeutic-target-in-squamous-cell-lung-cancer/ 2015-12-30T13:55:48+00:00 https://lungcancergroup.de/project/clinical-pharmacokinetics-of-tyrosine-kinase-inhibitors-focus-on-4-anilinoquinazolines/ 2015-12-30T13:57:08+00:00 https://lungcancergroup.de/project/benchmarking-of-mutation-diagnostics-in-clinical-lung-cancer-specimens/ 2015-12-30T13:58:28+00:00 https://lungcancergroup.de/project/blood-based-gene-expression-signatures-for-early-detection-of-lung-cancer/ 2015-12-30T13:59:47+00:00 https://lungcancergroup.de/project/early-prediction-of-nonprogression-in-advanced-non-small-cell-lung-cancer-treated-with-erlotinib-by-using-18ffluorodeoxyglucose-and-18ffluorothymidine-positron-emission-tomography/ 2015-12-30T14:01:03+00:00 https://lungcancergroup.de/project/vandetanib-plus-pemetrexed-for-the-second-line-treatment-of-advanced-non-small-cell-lung-cancer-a-randomized-double-blind-phase-iii-trial-zeal/ 2015-12-30T14:02:21+00:00 https://lungcancergroup.de/project/molecular-diagnostics-of-lung-cancer-for-treatment-stratification/ 2015-12-30T14:03:41+00:00 https://lungcancergroup.de/project/quantitative-analysis-of-response-to-treatment-with-erlotinib-in-advanced-nonsmall-cell-lung-cancer-using-18f-fdg-and-3-deoxy-3-18f-fluorothymidine-pet/ 2015-12-30T14:10:49+00:00 https://lungcancergroup.de/project/focal-amplification-of-fgfr1-associates-with-therapeutically-tractable-fgfr1-dependency-in-squamous-cell-lung-cancer/ 2015-12-30T19:15:22+00:00 https://lungcancergroup.de/project/targeted-next-generation-sequencing-of-dna-regions-proximal-to-a-conserved-gxgxxg-signaling-motif-enables-systematic-discovery-of-tyrosine-kinase-fusions-in-cancer/ 2015-12-30T19:16:58+00:00 https://lungcancergroup.de/project/cytohesins-are-cytoplasmic-erbb-receptor-activators/ 2015-12-30T19:18:30+00:00 https://lungcancergroup.de/project/replication-of-lung-cancer-susceptibility-loci-at-chromosomes-15q25-5p15-and-6p21-a-pooled-analysis-from-the-international-lung-cancer-consortium/ 2015-12-30T19:20:02+00:00 https://lungcancergroup.de/project/implementing-who-recommendations-for-palliative-care-into-routine-lung-cancer-therapy-a-feasibility-project/ 2015-12-30T19:21:26+00:00 https://lungcancergroup.de/project/synthesis-and-biological-evaluation-of-4-anilinoquinolines-as-potent-inhibitors-of-epidermal-growth-factor-receptor/ 2015-12-30T19:23:41+00:00 https://lungcancergroup.de/project/osteoblastic-response-in-patients-with-non-small-cell-lung-cancer-with-activating-egfr-mutations-and-bone-metastases-during-treatment-with-egfr-kinase-inhibitors/ 2015-12-30T19:25:23+00:00 https://lungcancergroup.de/project/identification-of-lung-cancer-with-high-sensitivity-and-specificity-by-blood-testing/ 2015-12-30T19:26:58+00:00 https://lungcancergroup.de/project/chemogenomic-profiling-provides-insights-into-the-limited-activity-of-irreversible-egfr-inhibitors-in-tumor-cells-expressing-the-t790m-egfr-resistance-mutation/ 2015-12-30T19:28:25+00:00 https://lungcancergroup.de/project/analysis-of-compound-synergy-in-high-throughput-cellular-screens-by-population-based-lifetime-modeling/ 2015-12-30T19:29:53+00:00 https://lungcancergroup.de/en/project/targeted-therapy-for-patients-with-braf-mutant-lung-cancer-results-from-the-european-euraf-cohort/ 2016-01-06T15:30:43+00:00 https://lungcancergroup.de/en/project/impact-of-petct-image-reconstruction-methods-and-liver-uptake-normalization-strategies-on-quantitative-image-analysis/ 2016-01-06T15:37:38+00:00 https://lungcancergroup.de/project/notch-ascl1-p53-und-rb-aenderungen-definieren-einen-alternativen-weg-fahr-neuroendokrinen-und-kleinzelligen-lungenkarzinomen/ 2016-03-07T14:12:46+00:00 https://lungcancergroup.de/en/project/notch-ascl1-p53-und-rb-aenderungen-definieren-einen-alternativen-weg-fahr-neuroendokrinen-und-kleinzelligen-lungenkarzinomen/ 2016-03-07T14:12:47+00:00 https://lungcancergroup.de/en/project/implementing-amplicon-based-next-generation-sequencing-in-the-diagnosis-of-small-cell-lung-carcinoma-metastases/ 2016-03-07T14:15:09+00:00 https://lungcancergroup.de/project/implementing-amplicon-based-next-generation-sequencing-in-the-diagnosis-of-small-cell-lung-carcinoma-metastases/ 2016-03-07T14:15:09+00:00 https://lungcancergroup.de/project/a-synergistic-interaction-between-chk1-and-mk2-inhibitors-in-kras-mutant-cancer/ 2016-03-07T14:19:04+00:00 https://lungcancergroup.de/en/project/a-synergistic-interaction-between-chk1-and-mk2-inhibitors-in-kras-mutant-cancer/ 2016-03-07T14:19:05+00:00 https://lungcancergroup.de/en/project/spatial-tumor-heterogeneity-in-lung-cancer-with-acquired-epidermal-growth-factor-receptor-tyrosine-kinase-inhibitor-resistance-targeting-high-level-met-amplification-and-egfr-t790m-mutation-occurring/ 2016-03-07T14:30:18+00:00 https://lungcancergroup.de/project/spatial-tumor-heterogeneity-in-lung-cancer-with-acquired-epidermal-growth-factor-receptor-tyrosine-kinase-inhibitor-resistance-targeting-high-level-met-amplification-and-egfr-t790m-mutation-occurring/ 2016-03-07T14:30:18+00:00 https://lungcancergroup.de/en/project/ros1-rearrangements-in-lung-adenocarcinoma-prognostic-impact-therapeutic-options-and-genetic-variability/ 2016-03-07T14:31:25+00:00 https://lungcancergroup.de/project/ros1-rearrangements-in-lung-adenocarcinoma-prognostic-impact-therapeutic-options-and-genetic-variability/ 2016-03-07T14:31:25+00:00 https://lungcancergroup.de/en/project/crizotinib-therapy-for-advanced-lung-adenocarcinoma-and-a-ros1-rearrangement-results-from-the-euros1-cohort/ 2016-03-07T14:33:00+00:00 https://lungcancergroup.de/project/crizotinib-therapy-for-advanced-lung-adenocarcinoma-and-a-ros1-rearrangement-results-from-the-euros1-cohort/ 2016-03-07T14:33:00+00:00 https://lungcancergroup.de/project/activity-and-safety-of-nivolumab-an-anti-pd-1-immune-checkpoint-inhibitor-for-patients-with-advanced-refractory-squamous-non-small-cell-lung-cancer-checkmate-063-a-phase-2-single-arm-trial/ 2016-03-07T14:34:37+00:00 https://lungcancergroup.de/en/project/activity-and-safety-of-nivolumab-an-anti-pd-1-immune-checkpoint-inhibitor-for-patients-with-advanced-refractory-squamous-non-small-cell-lung-cancer-checkmate-063-a-phase-2-single-arm-trial/ 2016-03-07T14:34:38+00:00 https://lungcancergroup.de/project/management-of-crizotinib-therapy-for-alk-rearranged-non-small-cell-lung-carcinoma-an-expert-consensus-2/ 2016-03-07T14:35:11+00:00 https://lungcancergroup.de/en/project/management-of-crizotinib-therapy-for-alk-rearranged-non-small-cell-lung-carcinoma-an-expert-consensus-2/ 2016-03-07T14:35:11+00:00 https://lungcancergroup.de/en/project/pd-l1-expression-in-small-cell-neuroendocrine-carcinomas-2/ 2016-03-07T14:39:11+00:00 https://lungcancergroup.de/project/pd-l1-expression-in-small-cell-neuroendocrine-carcinomas-2/ 2016-03-07T14:39:11+00:00 https://lungcancergroup.de/en/project/identification-of-novel-fusion-genes-in-lung-cancer-using-breakpoint-assembly-of-transcriptome-sequencing-data/ 2016-03-07T14:39:59+00:00 https://lungcancergroup.de/project/identification-of-novel-fusion-genes-in-lung-cancer-using-breakpoint-assembly-of-transcriptome-sequencing-data/ 2016-03-07T14:39:59+00:00 https://lungcancergroup.de/project/met-amplification-status-in-therapy-naive-adeno-and-squamous-cell-carcinomas-of-the-lung/ 2016-03-07T14:40:54+00:00 https://lungcancergroup.de/project/pik3ca-mutations-in-non-small-cell-lung-cancer-nsclc-genetic-heterogeneity-prognostic-impact-and-incidence-of-prior-malignancies-2/ 2016-03-07T14:44:18+00:00 https://lungcancergroup.de/project/vemurafenib-in-multiple-nonmelanoma-cancers-with-braf-v600-mutations/ 2016-03-07T14:58:57+00:00 https://lungcancergroup.de/project/alk-diagnostics-in-nsclc-immunohistochemistry-ihc-andor-fluorescence-in-situ-hybridisation-fish/ 2016-04-01T12:50:43+00:00 https://lungcancergroup.de/project/alk-diagnostics-in-nsclc-immunohistochemistry-ihc-andor-fluorescence-in-situ-hybridisation-fish/ 2016-04-22T12:53:44+00:00 https://lungcancergroup.de/en/project/alk-diagnostics-nsclc-immunohistochemistry-ihc-andor-fluorescence-situ-hybridisation-fish/ 2016-04-22T13:17:29+00:00 https://lungcancergroup.de/project/activity-and-safety-of-ceritinib-in-patients-with-alk-rearranged-non-small-cell-lung-cancer-ascend-1-updated-results-from-the-multicentre-open-label-phase-1-trial/ 2016-04-22T14:14:16+00:00 https://lungcancergroup.de/en/project/activity-safety-ceritinib-patients-alk-rearranged-non-small-cell-lung-cancer-ascend-1-updated-results-multicentre-open-label-phase-1-trial/ 2016-04-22T14:15:15+00:00 https://lungcancergroup.de/project/clinicopathological-characteristics-of-ret-rearranged-lung-cancer-in-european-patients/ 2016-04-25T07:58:18+00:00 https://lungcancergroup.de/en/project/clinicopathological-characteristics-of-ret-rearranged-lung-cancer-in-european-patients/ 2016-04-25T07:58:19+00:00 https://lungcancergroup.de/project/afatinib-in-non-small-cell-lung-cancer-harboring-uncommon-egfr-mutations-pretreated-with-reversible-egfr-inhibitors/ 2016-04-25T07:59:05+00:00 https://lungcancergroup.de/en/project/afatinib-in-non-small-cell-lung-cancer-harboring-uncommon-egfr-mutations-pretreated-with-reversible-egfr-inhibitors/ 2016-04-25T07:59:05+00:00 https://lungcancergroup.de/project/developments-in-oncological-positron-emission-tomographycomputed-tomography-assessment/ 2016-04-25T08:00:32+00:00 https://lungcancergroup.de/project/a-modeling-and-simulation-framework-for-adverse-events-in-erlotinib-treated-non-small-cell-lung-cancer-patients/ 2016-04-25T08:06:28+00:00 https://lungcancergroup.de/en/project/a-modeling-and-simulation-framework-for-adverse-events-in-erlotinib-treated-non-small-cell-lung-cancer-patients/ 2016-04-25T08:07:10+00:00 https://lungcancergroup.de/project/comprehensive-genomic-profiles-of-small-cell-lung-cancer/ 2016-04-25T08:08:44+00:00 https://lungcancergroup.de/en/project/comprehensive-genomic-profiles-of-small-cell-lung-cancer/ 2016-04-25T08:08:44+00:00 https://lungcancergroup.de/project/implementation-of-amplicon-parallel-sequencing-leads-to-improvement-of-diagnosis-and-therapy-of-lung-cancer-patients/ 2016-04-25T08:10:04+00:00 https://lungcancergroup.de/en/project/implementation-of-amplicon-parallel-sequencing-leads-to-improvement-of-diagnosis-and-therapy-of-lung-cancer-patients/ 2016-04-25T08:10:58+00:00 https://lungcancergroup.de/en/project/modeling-tumor-dynamics-and-overall-survival-in-advanced-non-small-cell-lung-cancer-treated-with-erlotinib/ 2018-07-18T11:21:04+00:00 https://lungcancergroup.de/en/project/ daily 1.0